Alignment Healthcare (ALHC) Financials

$15.48 -0.05 (-0.32%)

Closing price 05/5/2025 04:00 PM Eastern

Extended Trading

$15.79 +0.31 (+2.00%)

As of 04:41 AM Eastern

Annual Income Statements for Alignment Healthcare

This table shows Alignment Healthcare's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-45	-23	-195	-150	-148	-128
Consolidated Net Income / (Loss)	-45	-23	-195	-150	-148	-128
Net Income / (Loss) Continuing Operations	-45	-23	-195	-150	-148	-128
Total Pre-Tax Income	-45	-23	-195	-149	-148	-128
Total Operating Income	-29	-5.26	-178	-129	-128	-102
Total Gross Profit	757	959	1,168	1,434	1,824	2,704
Total Revenue	757	959	1,168	1,434	1,824	2,704
Operating Revenue	757	959	1,168	1,434	1,824	2,704
Total Cost of Revenue	0.00	0.00	0.00	0.00	0.00	0.00
Total Operating Expenses	786	964	1,346	1,563	1,951	2,805
Selling, General & Admin Expense	110	156	291	296	307	371
Depreciation Expense	15	15	16	17	21	27
Other Operating Expenses / (Income)	661	793	1,039	1,250	1,623	2,407
Total Other Income / (Expense), net	-15	-18	-17	-20	-21	-27
Interest Expense	15	17	17	20	21	27
Income Tax Expense	0.00	0.00	0.00	0.34	-0.02	0.02
Net Income / (Loss) Attributable to Noncontrolling Interest	-	0.00	0.00	-0.09	-0.16	-0.04
Basic Earnings per Share	($0.33)	($0.15)	($1.14)	($0.83)	($0.79)	($0.67)
Weighted Average Basic Shares Outstanding	135.86M	152.13M	171.96M	181.21M	186.21M	190.79M
Diluted Earnings per Share	($0.33)	($0.15)	($1.14)	($0.83)	($0.79)	($0.67)
Weighted Average Diluted Shares Outstanding	135.86M	152.13M	171.96M	181.21M	186.21M	190.79M
Weighted Average Basic & Diluted Shares Outstanding	135.86M	152.13M	171.96M	181.21M	188.98M	191.83M

This table shows Alignment Healthcare's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-40	-57	-37	-28	-35	-47	-47	-24	-26	-31
Consolidated Net Income / (Loss)	-40	-57	-37	-28	-35	-47	-47	-24	-26	-31
Net Income / (Loss) Continuing Operations	-40	-58	-37	-28	-35	-47	-47	-24	-26	-31
Total Pre-Tax Income	-40	-57	-37	-28	-35	-47	-47	-24	-26	-31
Total Operating Income	-33	-52	-32	-24	-30	-42	-41	-18	-20	-23
Total Gross Profit	360	362	439	462	457	465	629	681	692	701
Total Revenue	360	362	439	462	457	465	629	681	692	701
Operating Revenue	360	362	439	462	457	465	629	681	692	701
Total Operating Expenses	394	414	472	486	486	507	670	700	712	724
Selling, General & Admin Expense	76	83	70	70	83	84	91	88	91	102
Depreciation Expense	4.46	4.69	4.92	5.20	5.50	5.80	5.98	6.49	7.64	6.76
Other Operating Expenses / (Income)	313	326	396	411	398	418	573	605	613	615
Total Other Income / (Expense), net	-6.67	-5.43	-4.88	-4.83	-5.47	-6.05	-5.47	-5.60	-6.94	-8.56
Interest Expense	6.80	4.79	5.02	5.26	5.47	5.48	5.43	5.69	6.94	8.51
Income Tax Expense	0.17	0.17	0.00	0.00	0.00	-0.02	0.00	0.02	-0.01	0.01
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	-0.09	-0.09	-0.02	-0.03	-0.02	-0.05	0.01	-0.02	0.03
Basic Earnings per Share	($0.22)	($0.32)	($0.20)	($0.15)	($0.19)	($0.25)	($0.25)	($0.13)	($0.14)	($0.15)
Weighted Average Basic Shares Outstanding	182.12M	181.21M	183.11M	185.99M	187.33M	186.21M	189.01M	190.89M	191.36M	190.79M
Diluted Earnings per Share	($0.22)	($0.32)	($0.20)	($0.15)	($0.19)	($0.25)	($0.25)	($0.13)	($0.14)	($0.15)
Weighted Average Diluted Shares Outstanding	182.12M	181.21M	183.11M	185.99M	187.33M	186.21M	189.01M	190.89M	191.36M	190.79M
Weighted Average Basic & Diluted Shares Outstanding	0.00	181.21M	183.11M	185.99M	0.00	188.98M	191.20M	191.30M	191.70M	191.83M

This table details how cash moves in and out of Alignment Healthcare's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	52	121	261	-57	-206	230
Net Cash From Operating Activities	9.21	7.56	-79	-45	-59	35
Net Cash From Continuing Operating Activities	9.21	7.56	-79	-45	-59	35
Net Income / (Loss) Continuing Operations	-45	-23	-195	-150	-148	-128
Consolidated Net Income / (Loss)	-45	-23	-195	-150	-148	-128
Depreciation Expense	17	15	16	17	22	27
Amortization Expense	1.95	2.19	2.25	1.85	1.25	1.29
Non-Cash Adjustments To Reconcile Net Income	6.41	9.58	114	72	64	74
Changes in Operating Assets and Liabilities, net	29	3.25	-16	13	2.03	61
Net Cash From Investing Activities	-10	-16	-21	-28	-147	39
Net Cash From Continuing Investing Activities	-10	-16	-21	-28	-147	39
Purchase of Property, Plant & Equipment	-10	-16	-18	-28	-36	-41
Purchase of Investments	-0.32	-1.58	-2.48	-2.83	-379	-82
Sale of Property, Plant & Equipment	0.00	0.10	-	0.00	0.00	0.01
Sale and/or Maturity of Investments	0.33	0.83	1.43	2.43	268	163
Net Cash From Financing Activities	53	130	360	17	0.11	156
Net Cash From Continuing Financing Activities	53	130	360	17	0.11	156
Repayment of Debt	-0.85	0.00	0.00	-148	0.00	-224
Payment of Dividends	0.00	0.00	0.00	-0.10	0.00	0.00
Issuance of Debt	55	0.00	0.00	165	0.00	380
Issuance of Common Equity	0.50	135	391	0.07	0.11	0.02
Other Financing Activities, net	-	-	-	0.00	0.00	-0.20
Cash Interest Paid	9.53	11	11	22	19	22

This table details how cash moves in and out of Alignment Healthcare's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	114	-158	-25	11	-3.62	-188	36	100	1.63	92
Net Cash From Operating Activities	105	-149	85	37	5.99	-187	-6.24	24	26	-8.71
Net Cash From Continuing Operating Activities	105	-149	85	37	5.99	-187	-6.24	24	26	-8.71
Net Income / (Loss) Continuing Operations	-40	-57	-37	-28	-35	-47	-47	-24	-26	-31
Consolidated Net Income / (Loss)	-40	-57	-37	-28	-35	-47	-47	-24	-26	-31
Depreciation Expense	4.51	4.75	4.98	5.26	5.56	5.86	6.03	6.54	7.69	6.81
Amortization Expense	0.48	0.23	0.31	0.43	0.30	0.22	0.52	0.09	0.37	0.32
Non-Cash Adjustments To Reconcile Net Income	8.30	19	22	12	12	17	20	17	17	19
Changes in Operating Assets and Liabilities, net	132	-117	95	47	23	-164	13	24	27	-3.94
Net Cash From Investing Activities	-8.13	-8.11	-110	-26	-9.61	-1.02	43	27	-25	-5.92
Net Cash From Continuing Investing Activities	-8.13	-8.11	-110	-26	-9.61	-1.02	43	27	-25	-5.92
Purchase of Property, Plant & Equipment	-7.83	-8.11	-7.29	-8.56	-9.55	-11	-11	-12	-9.28	-9.28
Purchase of Investments	-1.73	-	-104	-53	-125	-97	-22	-18	-36	-6.68
Sale and/or Maturity of Investments	1.43	-	1.10	35	125	107	75	57	20	10
Net Cash From Financing Activities	17	-0.53	0.03	0.03	-	0.05	-0.34	49	-	107
Net Cash From Continuing Financing Activities	17	-0.53	0.03	0.03	-	0.05	-0.34	49	-	107
Repayment of Debt	-	-0.60	-	-	-	-	-	-	-	-223
Issuance of Debt	-	-	-	-	-	-	-	-	-	330
Other Financing Activities, net	-	-	0.00	-	-	-	-0.35	-	-	0.16
Cash Interest Paid	17	-	4.28	4.71	4.96	5.22	5.18	5.07	5.36	6.56

This table presents Alignment Healthcare's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	339	631	634	592	782
Total Current Assets	265	553	545	484	662
Cash & Equivalents	207	467	410	203	433
Short-Term Investments	-	-	0.00	116	38
Accounts Receivable	40	59	93	120	154
Prepaid Expenses	17	28	42	45	37
Plant, Property, & Equipment, net	27	30	37	52	67
Total Noncurrent Assets	47	48	52	56	53
Goodwill	35	35	35	35	35
Intangible Assets	-	-	5.48	5.25	4.55
Other Noncurrent Operating Assets	12	13	12	16	14
Total Liabilities & Shareholders' Equity	339	631	634	592	782
Total Liabilities	308	325	395	434	681
Total Current Liabilities	153	167	230	263	352
Accounts Payable	16	17	32	24	22
Current Employee Benefit Liabilities	-	-	-	34	40
Other Current Liabilities	113	126	170	205	290
Total Noncurrent Liabilities	154	158	165	171	329
Long-Term Debt	144	151	161	162	321
Other Noncurrent Operating Liabilities	10	6.98	3.70	8.97	7.84
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	31	306	239	158	101
Total Preferred & Common Equity	31	306	238	157	100
Preferred Stock	0.00	0.00	0.00	0.00	0.00
Total Common Equity	31	306	238	157	100
Common Stock	410	889	970	1,037	1,108
Retained Earnings	-380	-583	-732	-880	-1,008
Noncontrolling Interest	0.00	0.02	1.18	1.13	1.10

This table presents Alignment Healthcare's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	778	762	784	771	633	716	692
Total Current Assets	692	671	684	667	521	599	574
Cash & Equivalents	567	384	395	392	239	339	340
Short-Term Investments	-	103	122	124	63	25	41
Accounts Receivable	88	125	89	106	165	183	139
Prepaid Expenses	36	58	77	46	54	52	54
Plant, Property, & Equipment, net	36	40	43	47	57	62	65
Total Noncurrent Assets	50	51	57	57	55	55	54
Goodwill	38	40	40	40	35	35	35
Intangible Assets	-	-	-	-	5.22	5.20	4.55
Other Noncurrent Operating Assets	12	11	17	17	15	15	15
Total Liabilities & Shareholders' Equity	778	762	784	771	633	716	692
Total Liabilities	505	538	572	581	501	591	577
Total Current Liabilities	340	374	402	410	331	372	358
Short-Term Debt	-	-	-	-	-	-	1.61
Accounts Payable	21	23	21	25	23	23	25
Accrued Expenses	31	25	26	35	32	33	34
Other Current Liabilities	171	186	207	203	276	315	297
Total Noncurrent Liabilities	165	164	171	171	170	220	219
Long-Term Debt	161	161	161	162	162	212	210
Other Noncurrent Operating Liabilities	4.46	2.50	9.21	9.32	8.44	8.18	8.19
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	272	224	211	190	132	125	116
Total Preferred & Common Equity	272	223	210	189	131	124	115
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	272	223	210	189	131	124	115
Common Stock	947	992	1,008	1,022	1,058	1,074	1,092
Retained Earnings	-675	-770	-798	-833	-927	-951	-977
Noncontrolling Interest	0.00	1.12	1.13	1.10	1.09	1.09	1.08

This table displays calculated financial ratios and metrics derived from Alignment Healthcare's official financial filings.

Metric	2019	2020	2021	2022	2023	2024
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-
Revenue Growth	0.00%	26.72%	21.74%	22.81%	27.16%	48.25%
EBITDA Growth	0.00%	203.14%	-1,468.64%	31.50%	4.03%	30.22%
EBIT Growth	0.00%	79.91%	-2,866.52%	27.67%	0.64%	20.55%
NOPAT Growth	0.00%	82.15%	-3,283.47%	27.76%	0.64%	20.55%
Net Income Growth	0.00%	48.75%	-751.81%	23.37%	0.98%	13.57%
EPS Growth	0.00%	54.55%	-660.00%	27.19%	4.82%	15.19%
Operating Cash Flow Growth	0.00%	-17.89%	-1,141.87%	42.33%	-30.29%	158.75%
Free Cash Flow Firm Growth	0.00%	0.00%	-610.46%	38.46%	-10.21%	78.22%
Invested Capital Growth	0.00%	0.00%	69.49%	5.84%	111.41%	-4,627.86%
Revenue Q/Q Growth	0.00%	0.00%	-13.97%	4.64%	6.02%	9.56%
EBITDA Q/Q Growth	0.00%	0.00%	-10.85%	-9.07%	9.71%	25.71%
EBIT Q/Q Growth	0.00%	0.00%	-9.63%	-7.84%	7.39%	16.02%
NOPAT Q/Q Growth	0.00%	0.00%	-9.65%	-7.20%	7.39%	16.02%
Net Income Q/Q Growth	0.00%	0.00%	-8.78%	-6.52%	6.18%	11.21%
EPS Q/Q Growth	0.00%	0.00%	-5.56%	-7.79%	8.14%	12.99%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	-34.00%	-161.64%	-182.06%	124.15%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	-474.76%	-49.38%	88.88%
Invested Capital Q/Q Growth	0.00%	0.00%	62.47%	93.06%	100.65%	9.53%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
EBITDA Margin	-1.49%	1.22%	-13.66%	-7.62%	-5.75%	-2.71%
Operating Margin	-3.90%	-0.55%	-15.25%	-8.97%	-7.01%	-3.76%
EBIT Margin	-3.94%	-0.63%	-15.23%	-8.97%	-7.01%	-3.76%
Profit (Net Income) Margin	-5.91%	-2.39%	-16.72%	-10.43%	-8.13%	-4.74%
Tax Burden Percent	100.00%	100.00%	100.00%	100.23%	99.99%	100.02%
Interest Burden Percent	149.93%	382.42%	109.81%	116.06%	115.94%	126.09%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	0.00%	-74.89%	-116.01%	-54.88%	-74.58%	-98.89%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	-9,369.88%	0.00%
Operating Return on Assets (OROA)	0.00%	-1.77%	-36.69%	-20.34%	-20.86%	-14.78%
Return on Assets (ROA)	0.00%	-6.77%	-40.29%	-23.66%	-24.18%	-18.64%
Return on Common Equity (ROCE)	0.00%	-74.89%	-116.01%	-54.76%	-74.14%	-98.04%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-74.89%	-63.81%	-62.84%	-94.41%	-128.26%
Net Operating Profit after Tax (NOPAT)	-21	-3.68	-125	-90	-89	-71
NOPAT Margin	-2.73%	-0.38%	-10.67%	-6.28%	-4.91%	-2.63%
Net Nonoperating Expense Percent (NNEP)	0.00%	-60.95%	-37.26%	-21.11%	-28.94%	-37.22%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-22.50%	-27.97%	-16.83%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	14.55%	16.30%	24.92%	20.61%	16.86%	13.74%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	103.90%	100.55%	115.25%	108.97%	107.01%	103.76%
Earnings before Interest and Taxes (EBIT)	-30	-6.00	-178	-129	-128	-102
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-11	12	-160	-109	-105	-73
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	15.99	8.60	9.25	10.37	21.60
Price to Tangible Book Value (P/TBV)	0.00	0.00	9.72	11.13	13.93	35.66
Price to Revenue (P/Rev)	0.65	0.51	2.25	1.54	0.89	0.80
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	1,381.12	0.00
Enterprise Value to Revenue (EV/Rev)	0.00	0.44	1.98	1.36	0.81	0.74
Enterprise Value to EBITDA (EV/EBITDA)	0.00	36.58	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	56.40	0.00	0.00	0.00	57.76
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	14.78	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	0.00	4.71	0.49	0.67	1.02	3.18
Long-Term Debt to Equity	0.00	4.71	0.49	0.67	1.02	3.18
Financial Leverage	0.00	-2.06	-1.13	-1.04	-1.02	-1.18
Leverage Ratio	0.00	11.06	2.88	2.32	3.08	5.30
Compound Leverage Factor	0.00	42.29	3.16	2.69	3.58	6.69
Debt to Total Capital	0.00%	82.49%	32.98%	40.21%	50.58%	76.10%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	82.49%	32.98%	40.21%	50.58%	76.10%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.29%	0.35%	0.26%
Common Equity to Total Capital	0.00%	17.51%	67.01%	59.50%	49.06%	23.64%
Debt to EBITDA	0.00	12.37	-0.94	-1.47	-1.54	-4.39
Net Debt to EBITDA	0.00	-5.42	1.98	2.27	1.50	2.04
Long-Term Debt to EBITDA	0.00	12.37	-0.94	-1.47	-1.54	-4.39
Debt to NOPAT	0.00	-39.13	-1.21	-1.79	-1.81	-4.52
Net Debt to NOPAT	0.00	17.14	2.53	2.76	1.75	2.10
Long-Term Debt to NOPAT	0.00	-39.13	-1.21	-1.79	-1.81	-4.52
Altman Z-Score	0.00	2.55	5.22	3.92	2.99	3.60
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.22%	0.58%	0.86%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	0.00	1.72	3.31	2.37	1.84	1.88
Quick Ratio	0.00	1.61	3.14	2.18	1.67	1.78
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	29	-147	-91	-100	-22
Operating Cash Flow to CapEx	89.88%	48.44%	-429.06%	-163.31%	-164.43%	83.98%
Free Cash Flow to Firm to Interest Expense	0.00	1.70	-8.44	-4.42	-4.70	-0.82
Operating Cash Flow to Interest Expense	0.62	0.45	-4.52	-2.22	-2.79	1.31
Operating Cash Flow Less CapEx to Interest Expense	-0.07	-0.48	-5.57	-3.58	-4.48	-0.25
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.00	2.83	2.41	2.27	2.98	3.94
Accounts Receivable Turnover	0.00	23.90	23.67	18.95	17.15	19.76
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	35.34	40.62	42.48	40.95	45.42
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	15.27	15.42	19.27	21.28	18.47
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	0.00	15.27	15.42	19.27	21.28	18.47
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	0.00	-33	-9.93	-9.35	1.07	-48
Invested Capital Turnover	0.00	-58.97	-55.01	-148.85	-440.54	-114.56
Increase / (Decrease) in Invested Capital	0.00	-33	23	0.58	10	-49
Enterprise Value (EV)	0.00	426	2,317	1,955	1,472	2,008
Market Capitalization	490	490	2,633	2,202	1,628	2,157
Book Value per Share	$0.00	$0.20	$1.63	$1.27	$0.83	$0.52
Tangible Book Value per Share	$0.00	($0.03)	$1.45	$1.06	$0.62	$0.32
Total Capital	0.00	175	457	400	320	422
Total Debt	0.00	144	151	161	162	321
Total Long-Term Debt	0.00	144	151	161	162	321
Net Debt	0.00	-63	-316	-249	-157	-149
Capital Expenditures (CapEx)	10	16	18	28	36	41
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-96	-81	-95	-98	-161
Debt-free Net Working Capital (DFNWC)	0.00	111	386	315	221	310
Net Working Capital (NWC)	0.00	111	386	315	221	310
Net Nonoperating Expense (NNE)	24	19	71	60	59	57
Net Nonoperating Obligations (NNO)	0.00	-63	-316	-249	-157	-149
Total Depreciation and Amortization (D&A)	19	18	18	19	23	28
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-10.02%	-6.94%	-6.62%	-5.39%	-5.95%
Debt-free Net Working Capital to Revenue	0.00%	11.60%	33.02%	21.94%	12.09%	11.46%
Net Working Capital to Revenue	0.00%	11.60%	33.02%	21.94%	12.09%	11.46%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	($1.14)	($0.83)	($0.79)	($0.67)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	187.07M	187.28M	186.21M	190.79M
Adjusted Diluted Earnings per Share	$0.00	$0.00	($1.14)	($0.83)	($0.79)	($0.67)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	187.07M	187.28M	186.21M	190.79M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	($1.14)	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	171.96M	181.21M	188.98M	191.83M
Normalized Net Operating Profit after Tax (NOPAT)	-21	-3.68	-125	-90	-89	-71
Normalized NOPAT Margin	-2.73%	-0.38%	-10.67%	-6.28%	-4.91%	-2.63%
Pre Tax Income Margin	-5.91%	-2.39%	-16.72%	-10.41%	-8.13%	-4.74%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	-2.00	-0.35	-10.20	-6.28	-6.02	-3.82
NOPAT to Interest Expense	-1.39	-0.22	-7.15	-4.40	-4.21	-2.68
EBIT Less CapEx to Interest Expense	-2.69	-1.28	-11.25	-7.64	-7.72	-5.38
NOPAT Less CapEx to Interest Expense	-2.07	-1.14	-8.20	-5.75	-5.91	-4.23
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	-0.07%	0.00%	0.00%
Augmented Payout Ratio	-4.43%	-21.27%	-15.61%	-0.07%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Alignment Healthcare's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	22.79%	21.30%	27.10%	26.17%	26.74%	28.63%	43.14%	47.34%	51.61%	50.68%
EBITDA Growth	22.91%	-21.89%	15.05%	-1,150.04%	15.55%	23.95%	-27.84%	33.52%	51.99%	56.96%
EBIT Growth	19.62%	-20.11%	11.16%	-274.33%	10.59%	19.56%	-27.19%	21.27%	34.39%	46.21%
NOPAT Growth	19.40%	-19.88%	10.93%	-255.88%	10.94%	19.56%	-26.52%	22.30%	34.39%	46.21%
Net Income Growth	12.16%	-19.15%	8.44%	-146.06%	12.85%	17.13%	-24.63%	15.76%	24.65%	34.23%
EPS Growth	15.38%	-23.08%	13.04%	-150.00%	13.64%	21.88%	-25.00%	13.33%	26.32%	40.00%
Operating Cash Flow Growth	714.00%	-395.33%	831.31%	259.06%	-94.30%	-25.59%	-107.33%	-36.71%	337.08%	95.35%
Free Cash Flow Firm Growth	3,396.85%	30.13%	245.10%	2,161.49%	-89.49%	-7.28%	-261.51%	-206.40%	-1,498.62%	184.41%
Invested Capital Growth	-409.11%	5.84%	-3,017.27%	-2,490.05%	-22.09%	111.41%	92.54%	81.27%	67.54%	-4,627.86%
Revenue Q/Q Growth	-1.67%	0.41%	21.38%	5.29%	-1.23%	1.90%	35.07%	8.38%	1.64%	1.27%
EBITDA Q/Q Growth	-1,916.39%	-66.56%	43.53%	35.20%	-36.23%	-49.99%	14.80%	66.30%	1.62%	-34.46%
EBIT Q/Q Growth	-436.24%	-56.57%	38.86%	28.19%	-28.09%	-40.86%	1.49%	55.55%	-6.74%	-15.49%
NOPAT Q/Q Growth	-402.56%	-55.96%	37.65%	27.18%	-25.77%	-40.86%	1.93%	55.28%	-6.20%	-15.49%
Net Income Q/Q Growth	-247.56%	-41.61%	34.43%	23.75%	-23.10%	-34.65%	1.39%	48.46%	-10.11%	-17.54%
EPS Q/Q Growth	-266.67%	-45.45%	37.50%	25.00%	-26.67%	-31.58%	0.00%	48.00%	-7.69%	-7.14%
Operating Cash Flow Q/Q Growth	915.26%	-241.99%	157.02%	-56.32%	-83.88%	-3,228.60%	96.67%	477.19%	11.31%	-133.26%
Free Cash Flow Firm Q/Q Growth	1,522.83%	-143.70%	306.85%	60.29%	-92.74%	-545.89%	-211.43%	-5.59%	4.61%	126.91%
Invested Capital Q/Q Growth	-2,304.45%	93.06%	-998.80%	-41.23%	-13.34%	100.65%	-819.04%	-254.44%	-96.37%	9.53%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
EBITDA Margin	-7.85%	-13.02%	-6.16%	-3.79%	-5.23%	-7.70%	-5.50%	-1.71%	-1.66%	-2.20%
Operating Margin	-9.27%	-14.40%	-7.40%	-5.12%	-6.52%	-9.01%	-6.54%	-2.70%	-2.82%	-3.22%
EBIT Margin	-9.24%	-14.40%	-7.37%	-5.02%	-6.52%	-9.01%	-6.55%	-2.68%	-2.82%	-3.22%
Profit (Net Income) Margin	-11.17%	-15.75%	-8.51%	-6.16%	-7.68%	-10.15%	-7.41%	-3.52%	-3.82%	-4.43%
Tax Burden Percent	100.42%	100.30%	100.00%	100.00%	100.00%	99.95%	100.00%	100.09%	99.97%	100.02%
Interest Burden Percent	120.44%	109.05%	115.51%	122.65%	117.88%	112.75%	113.19%	131.12%	135.42%	137.76%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	-47.05%	-54.88%	-56.53%	-64.62%	-68.41%	-74.58%	-88.42%	-91.03%	-94.51%	-98.89%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	-9,369.88%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	-17.65%	-32.66%	-15.98%	-11.25%	-14.48%	-26.80%	-18.89%	-7.99%	-9.51%	-12.65%
Return on Assets (ROA)	-21.34%	-35.73%	-18.46%	-13.80%	-17.06%	-30.20%	-21.38%	-10.49%	-12.88%	-17.43%
Return on Common Equity (ROCE)	-47.05%	-54.76%	-56.41%	-64.48%	-68.24%	-74.14%	-87.88%	-90.43%	-93.84%	-98.04%
Return on Equity Simple (ROE_SIMPLE)	-51.62%	0.00%	-65.61%	-77.68%	-83.78%	0.00%	-120.20%	-123.59%	-125.92%	0.00%
Net Operating Profit after Tax (NOPAT)	-23	-36	-23	-17	-21	-29	-29	-13	-14	-16
NOPAT Margin	-6.49%	-10.08%	-5.18%	-3.58%	-4.56%	-6.30%	-4.58%	-1.89%	-1.97%	-2.25%
Net Nonoperating Expense Percent (NNEP)	-4.45%	-7.27%	-4.69%	-3.64%	-3.75%	-8.82%	-7.63%	-4.38%	-4.88%	-9.98%
Return On Investment Capital (ROIC_SIMPLE)	-	-9.11%	-	-	-	-9.17%	-	-	-	-3.74%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	21.22%	23.00%	16.03%	15.18%	18.19%	17.99%	14.40%	12.90%	13.12%	14.56%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	109.27%	114.40%	107.40%	105.12%	106.52%	109.01%	106.54%	102.70%	102.82%	103.22%
Earnings before Interest and Taxes (EBIT)	-33	-52	-32	-23	-30	-42	-41	-18	-20	-23
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-28	-47	-27	-18	-24	-36	-35	-12	-11	-15
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	8.15	9.25	5.35	5.16	6.94	10.37	7.16	12.09	19.74	21.60
Price to Tangible Book Value (P/TBV)	9.45	11.13	6.52	6.38	8.81	13.93	10.32	17.87	30.08	35.66
Price to Revenue (P/Rev)	1.62	1.54	0.78	0.67	0.76	0.89	0.47	0.67	0.92	0.80
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	1,381.12	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	1.32	1.36	0.57	0.45	0.56	0.81	0.40	0.60	0.85	0.74
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	24.56	0.00	16.87	9.32	0.00	0.00	0.00	0.00	0.00	57.76
Enterprise Value to Free Cash Flow (EV/FCFF)	74.86	0.00	71.35	18.09	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.59	0.67	0.72	0.76	0.85	1.02	1.23	1.70	1.83	3.18
Long-Term Debt to Equity	0.59	0.67	0.72	0.76	0.85	1.02	1.23	1.70	1.82	3.18
Financial Leverage	-1.27	-1.04	-1.20	-1.30	-1.65	-1.02	-1.31	-1.51	-1.71	-1.18
Leverage Ratio	2.40	2.32	2.72	2.87	3.35	3.08	3.92	4.46	4.79	5.30
Compound Leverage Factor	2.89	2.53	3.15	3.52	3.95	3.48	4.44	5.85	6.49	7.31
Debt to Total Capital	37.12%	40.21%	41.84%	43.32%	46.01%	50.58%	55.10%	62.92%	64.71%	76.10%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.49%	0.00%
Long-Term Debt to Total Capital	37.12%	40.21%	41.84%	43.32%	46.01%	50.58%	55.10%	62.92%	64.22%	76.10%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.29%	0.29%	0.30%	0.31%	0.35%	0.37%	0.32%	0.33%	0.26%
Common Equity to Total Capital	62.88%	59.50%	57.87%	56.37%	53.67%	49.06%	44.53%	36.76%	34.96%	23.64%
Debt to EBITDA	-1.60	-1.47	-1.54	-1.34	-1.39	-1.54	-1.39	-1.91	-2.15	-4.39
Net Debt to EBITDA	4.06	2.27	3.12	2.95	3.05	1.50	1.20	1.37	1.72	2.04
Long-Term Debt to EBITDA	-1.60	-1.47	-1.54	-1.34	-1.39	-1.54	-1.39	-1.91	-2.14	-4.39
Debt to NOPAT	-1.91	-1.79	-1.85	-1.63	-1.67	-1.81	-1.70	-2.31	-2.50	-4.52
Net Debt to NOPAT	4.84	2.76	3.74	3.59	3.66	1.75	1.46	1.66	2.00	2.10
Long-Term Debt to NOPAT	-1.91	-1.79	-1.85	-1.63	-1.67	-1.81	-1.70	-2.31	-2.49	-4.52
Altman Z-Score	3.58	4.32	2.25	2.12	2.34	3.46	2.40	3.07	4.22	3.93
Noncontrolling Interest Sharing Ratio	0.00%	0.22%	0.22%	0.22%	0.24%	0.58%	0.62%	0.66%	0.71%	0.86%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.03	2.37	1.79	1.70	1.63	1.84	1.57	1.61	1.60	1.88
Quick Ratio	1.93	2.18	1.64	1.51	1.51	1.67	1.41	1.47	1.45	1.78
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	85	-37	77	123	8.91	-40	-124	-131	-125	34
Operating Cash Flow to CapEx	1,342.87%	-1,841.16%	1,168.29%	434.31%	62.72%	-1,769.05%	-56.09%	200.54%	282.22%	-93.83%
Free Cash Flow to Firm to Interest Expense	12.47	-7.73	15.27	23.35	1.63	-7.25	-22.81	-22.97	-17.97	3.94
Operating Cash Flow to Interest Expense	15.46	-31.14	16.96	7.07	1.10	-34.18	-1.15	4.13	3.78	-1.02
Operating Cash Flow Less CapEx to Interest Expense	14.31	-32.83	15.51	5.44	-0.65	-36.12	-3.20	2.07	2.44	-2.11
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.91	2.27	2.17	2.24	2.22	2.98	2.89	2.98	3.37	3.94
Accounts Receivable Turnover	20.17	18.95	14.56	17.37	17.76	17.15	13.87	16.40	20.20	19.76
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	40.86	42.48	42.82	42.48	41.58	40.95	41.58	42.33	44.12	45.42
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	18.09	19.27	25.06	21.01	20.56	21.28	26.32	22.25	18.07	18.47
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	18.09	19.27	25.06	21.01	20.56	21.28	26.32	22.25	18.07	18.47
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	-135	-9.35	-103	-145	-164	1.07	-7.67	-27	-53	-48
Invested Capital Turnover	-17.02	-148.85	-28.83	-21.56	-11.51	-440.54	-36.49	-25.93	-22.67	-114.56
Increase / (Decrease) in Invested Capital	-108	0.58	-99	-139	-30	10	95	118	111	-49
Enterprise Value (EV)	1,810	1,955	866	728	955	1,472	799	1,344	2,093	2,008
Market Capitalization	2,217	2,202	1,191	1,083	1,308	1,628	938	1,495	2,261	2,157
Book Value per Share	$1.45	$1.27	$1.19	$1.11	$1.00	$0.83	$0.69	$0.65	$0.60	$0.52
Tangible Book Value per Share	$1.25	$1.06	$0.98	$0.90	$0.79	$0.62	$0.48	$0.44	$0.39	$0.32
Total Capital	433	400	385	372	351	320	294	337	328	422
Total Debt	161	161	161	161	162	162	162	212	212	321
Total Long-Term Debt	161	161	161	161	162	162	162	212	210	321
Net Debt	-407	-249	-327	-356	-354	-157	-140	-152	-169	-149
Capital Expenditures (CapEx)	7.83	8.11	7.29	8.56	9.55	11	11	12	9.28	9.28
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-216	-95	-191	-236	-259	-98	-112	-136	-164	-161
Debt-free Net Working Capital (DFNWC)	352	315	297	282	257	221	190	228	217	310
Net Working Capital (NWC)	352	315	297	282	257	221	190	228	216	310
Net Nonoperating Expense (NNE)	17	21	15	12	14	18	18	11	13	15
Net Nonoperating Obligations (NNO)	-407	-249	-327	-356	-354	-157	-140	-152	-169	-149
Total Depreciation and Amortization (D&A)	4.99	4.99	5.29	5.69	5.86	6.08	6.55	6.63	8.05	7.12
Debt-free, Cash-free Net Working Capital to Revenue	-15.73%	-6.62%	-12.50%	-14.52%	-15.05%	-5.39%	-5.55%	-6.10%	-6.64%	-5.95%
Debt-free Net Working Capital to Revenue	25.67%	21.94%	19.42%	17.35%	14.92%	12.09%	9.43%	10.20%	8.80%	11.46%
Net Working Capital to Revenue	25.67%	21.94%	19.42%	17.35%	14.92%	12.09%	9.43%	10.20%	8.73%	11.46%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.22)	($0.32)	($0.20)	($0.15)	($0.19)	($0.25)	($0.25)	($0.13)	($0.14)	($0.15)
Adjusted Weighted Average Basic Shares Outstanding	187.26M	181.21M	188.38M	188.40M	187.33M	186.21M	189.01M	190.89M	191.36M	190.79M
Adjusted Diluted Earnings per Share	($0.22)	($0.32)	($0.20)	($0.15)	($0.19)	($0.25)	($0.25)	($0.13)	($0.14)	($0.15)
Adjusted Weighted Average Diluted Shares Outstanding	187.26M	181.21M	188.38M	188.40M	187.33M	186.21M	189.01M	190.89M	191.36M	190.79M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	182.12M	181.21M	183.11M	185.99M	0.00	188.98M	191.20M	191.30M	191.70M	191.83M
Normalized Net Operating Profit after Tax (NOPAT)	-23	-36	-23	-17	-21	-29	-29	-13	-14	-16
Normalized NOPAT Margin	-6.49%	-10.08%	-5.18%	-3.58%	-4.56%	-6.30%	-4.58%	-1.89%	-1.97%	-2.25%
Pre Tax Income Margin	-11.12%	-15.71%	-8.51%	-6.16%	-7.68%	-10.15%	-7.41%	-3.52%	-3.82%	-4.43%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-4.89	-10.87	-6.45	-4.41	-5.44	-7.64	-7.58	-3.21	-2.81	-2.65
NOPAT to Interest Expense	-3.44	-7.61	-4.53	-3.15	-3.81	-5.35	-5.30	-2.26	-1.97	-1.85
EBIT Less CapEx to Interest Expense	-6.04	-12.56	-7.90	-6.04	-7.19	-9.58	-9.63	-5.28	-4.15	-3.74
NOPAT Less CapEx to Interest Expense	-4.59	-9.30	-5.98	-4.77	-5.56	-7.28	-7.35	-4.32	-3.31	-2.94
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-0.08%	-0.07%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-0.08%	-0.07%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Alignment Healthcare's Financials

When does Alignment Healthcare's financial year end?

According to the most recent income statement we have on file, Alignment Healthcare's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Alignment Healthcare's net income changed over the last 5 years?

Alignment Healthcare's net income appears to be on an upward trend, with a most recent value of -$128.07 million in 2024, rising from -$44.73 million in 2019. The previous period was -$148.17 million in 2023. Find out what analysts predict for Alignment Healthcare in the coming months.

What is Alignment Healthcare's operating income?

Alignment Healthcare's total operating income in 2024 was -$101.56 million, based on the following breakdown:

Total Gross Profit: $2.70 billion
Total Operating Expenses: $2.81 billion

How has Alignment Healthcare revenue changed over the last 5 years?

Over the last 5 years, Alignment Healthcare's total revenue changed from $756.96 million in 2019 to $2.70 billion in 2024, a change of 257.2%.

How much debt does Alignment Healthcare have?

Alignment Healthcare's total liabilities were at $681.11 million at the end of 2024, a 57.0% increase from 2023, and a 121.2% increase since 2020.

How much cash does Alignment Healthcare have?

In the past 4 years, Alignment Healthcare's cash and equivalents has ranged from $202.90 million in 2023 to $466.60 million in 2021, and is currently $432.86 million as of their latest financial filing in 2024.

How has Alignment Healthcare's book value per share changed over the last 5 years?

Over the last 5 years, Alignment Healthcare's book value per share changed from 0.00 in 2019 to 0.52 in 2024, a change of 52.1%.

Related Companies

This page (NASDAQ:ALHC) was last updated on 5/6/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alignment Healthcare (ALHC) Financials

Frequently Asked Questions About Alignment Healthcare's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Alignment Healthcare (ALHC) Financials

Annual Income Statements for Alignment Healthcare

Quarterly Income Statements for Alignment Healthcare

Annual Cash Flow Statements for Alignment Healthcare

Quarterly Cash Flow Statements for Alignment Healthcare

Annual Balance Sheets for Alignment Healthcare

Quarterly Balance Sheets for Alignment Healthcare

Annual Metrics and Ratios for Alignment Healthcare

Quarterly Metrics and Ratios for Alignment Healthcare

Frequently Asked Questions About Alignment Healthcare's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools